Significant Ownership of Clearline Capital LP

Signature - Title
Marc Majzner - Limited Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Clearline Capital LP.

Notify me when Clearline Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Clearline Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HRTX HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share 6.7% $18,108,154 +$3,733,614 12,235,239 +26% Clearline Capital LP 31 Dec 2025
XPER Xperi Inc. Common Stock (par value $0.001 per share) 6.4% $17,787,867 2,949,895 Clearline Capital LP 31 Dec 2025
TXMD TherapeuticsMD, Inc. Common Stock, par value $0.001 per share 5.5% $705,096 635,222 Clearline Capital LP 31 Dec 2024
MX MAGNACHIP SEMICONDUCTOR Corp Common Stock, par value $0.01 per share 4.1% $3,725,642 -$1,119,807 1,461,036 -23% Clearline Capital LP 31 Dec 2025

Schedules 13D/G Reported by Clearline Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.